Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Gilson Erin Leigh 2. Date of Event Requiring Statement (Month/Day/Year) 04/01/2026 3. Issuer Name and Ticker or Trading Symbol BALCHEM CORP [BCPC] (Last) (First) (Middle) C/O BALCHEM CORPORATION, 5 PARAGON DRIVE 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Accounting Officer 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) MONTVALE, NJ 07645 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock(1) 2,440 D Common Stock 46 I 401(k) Plan

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	02/15/2019(2)	02/15/2028	Common Stock	360	$74.57	D
Employee Stock Option (right to buy)	02/13/2020(2)	02/13/2029	Common Stock	1,000	$84.09	D
Employee Stock Option (right to buy)	02/13/2021(2)	02/13/2030	Common Stock	900	$111.94	D
Employee Stock Option (right to buy)	12/22/2021(2)	12/22/2030	Common Stock	1,500	$113.24	D
Employee Stock Option (right to buy)	02/11/2022(2)	02/11/2031	Common Stock	600	$119.13	D
Employee Stock Option (right to buy)	02/10/2023(2)	02/10/2032	Common Stock	600	$138.07	D
Employee Stock Option (right to buy)	02/08/2024(2)	02/08/2033	Common Stock	600	$138.09	D
Employee Stock Option (right to buy)	02/08/2025(2)	02/08/2034	Common Stock	600	$143.43	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Gilson Erin Leigh C/O BALCHEM CORPORATION 5 PARAGON DRIVE MONTVALE, NJ 07645			Chief Accounting Officer

Signatures

/s/ Travis Larsen, Attorney in Fact for Erin Leigh Gilson		04/07/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Ownership of 1,330 shares of restricted stock vests in Reporting Person 3 years following the grant dates and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Ownership of 1,110 shares of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
(2)	Options vest 20% after one year, 40% after two years, and 40% after three years.
Remarks: Exhibit 24 - Power of Attorney is attached.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.